Loading, please wait...
This CE activity was originally published in The Rx Consultant. If you received credit for it previously, you cannot receive credit for it again.Heart failure (HF) is a common condition that causes significant disability and death in the US and around the world. About 6.5 million adults in the US have HF – and despite advances in drug and device therapies, HF was a contributing cause of 1 in 8 deaths in 2017.The estimated total cost of HF (including health care, medication and missed work) in 2012 was almost $31 billion.The prevalence of HF continues to rise, and is expected to exceed 8 million people by 2030. By this time, the medical costs of HF management are projected to reach $53 billion annually.
This issue describes the physiology underlying different types of HF and reviews all aspects of the medications that are currently available and recommended for its management. Various factors and medications that can worsen HF are also discussed.
Fee
$10.00
CE Hours
1.50
CE Units
0.150
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses
Accreditation(s)
This CE activity was developed by The Rx Consultant, a publication of Continuing Education Network, Inc.
CE activities for Pharmacists and Pharmacy Technicians: This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours. CE credit is automatically reported to CPE Monitor. CE activities for Nurse Practitioners and Clinical Nurse Specialists:
This continuing education activity meets the requirements of:
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics. The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE. This is a pharmacotherapeutics/pharmacology CE activity.
|
|
|
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
To receive CE credit, the participant must read the monograph in its entirety, complete the online post-test and receive a score of 70% or greater, and complete the online evaluation.
Pharmacists and Pharmacy Technicians -
Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits cannot be reported to CPE Monitor.
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation are successfully completed.
Objectives
- Describe the health conditions that can lead to heart failure and the types of heart failure according to ejection fraction,ACCF/AHA stage, and NYHA functional class. Understand the relationship between heart failure and the renin angiotensin aldosterone system (RAAS) and the sympathetic nervous system (SNS).
- Regarding the major classes of heart failure medications, describe their role in therapy, adverse effects, and monitoring recommendations. List 4 medications that should be avoided in patients with heart failure.
- Counsel patients about heart failure, including signs and symptoms and recommended lifestyle changes.
Speaker(s)/Author(s)
|
Douglas Jennings, PharmD, FACC, FAHA, FCCP, FHFSA,BCPS Brief Bio : Douglas Jennings, PharmD, FACC, FAHA, FCCP, FHFSA,BCPS is an Associate Professor of Pharmacy Practice at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences at Long Island University, and the clinical pharmacist for the heart transplant and ventricular assist device teams at NewYork-Presbyterian Columbia University Medical Center. |
Activity Number
0428-0000-20-004-H01-P
Release Date:
Apr 23, 2020
Credit Expiration Date:
Apr 23, 2023
CE Hours
1.50
Fee
$10.00
The CE Activity developed by The Rx Consultant